Introduction
============

Esophageal fistulas caused by anastomotic leaks are the most common and serious adverse events after esophagectomy for esophageal cancer [@JR1687-1] [@JR1687-2] [@JR1687-3] . Esophageal fistulas are associated with high mortality due to recurrent aspiration and pulmonary infections. They can lead to a poor quality of life due to difficulty in oral intake, with long duration of hospital stay. In addition, they are sometimes intractable to several conservative management. Reoperation strategies are sometimes challenging because of adhesion, small space, and patients' conditions and increase the risk of morbidity and mortality.

Several endoscopic therapies for closure of esophageal fistulas have been reported [@JR1687-1] [@JR1687-3] [@JR1687-4] [@JR1687-5] [@JR1687-6] [@JR1687-7] . Although endoscopic stenting can close esophageal fistulas in some cases, high recurrence and many adverse events were reported, such as migration, and severe pain; especially in cases of aorto-esophageal fistulas, the stenting can result in death [@JR1687-1] [@JR1687-3] [@JR1687-4] . An over-the-scope-clipping (OTSC; Ovesco Endoscopy AG, Tubingen, Germany) system to close fistulas was also described [@JR1687-4] [@JR1687-5] [@JR1687-8] . However, fistulas sometimes have severe fibrosis, which is the most important predictor of OTSC failure and recurrence. In addition, the space for using an OTSC is very small in the residual esophagus after esophagectomy.

Recently, polyglycolic acid (PGA) sheets with fibrin glue have been used to close perforations and fistulas [@JR1687-6] [@JR1687-9] [@JR1687-10] . However, no studies have been reported on the use of PGA sheets with fibrin glue for just esophageal fistulas after esophagectomy. We investigated the safety and efficacy of PGA sheets with fibrin glue for esophageal fistulas after esophagectomy.

Patients and methods
====================

Patients
--------

This was a single-center prospective pilot study. The study protocol was approved by the ethics committee of the Osaka City University Hospital (approval no.: 3198) and registry in the University Hospital Medical Network Clinical Trial Registry (UMIN000019622). All patients provided written informed consent.

The enrolled patients (n = 5) met the following inclusion criteria: (1) patients who were diagnosed with an esophageal fistula after esophagectomy by esophagogastroduodenoscopy or contrast radiography; (2) age \> 20 years; and (3) provision of written informed consent regarding study participation. The exclusion criteria were as follows: (1) pregnancy or breastfeeding; (2) mental illness; (3) presence of serious complications (liver, kidney, or heart disease); (4) severe infection; (5) presence of severe bleeding or shock; (6) allergy to PGA sheets or fibrin glue; and (7) other reasons, which made the patient ineligible to participate in this study at the discretion of the chief investigator.

Outcome measure
---------------

The main outcome measure was incidence of adverse events (AEs). Secondary outcomes were incidence of closed fistulas and number and duration of the treatment period with the PGA sheets required to close the esophageal fistulas.

Application of PGA sheets and fibrin glue
-----------------------------------------

An upper gastrointestinal endoscope (GIF-Q260J; Olympus, Tokyo, Japan) and a standard electrosurgical generator (VIO300D; ERBE Elektromedizin GmbH, Tübingen, Germany) were used. First, we ablated the mucosa around the fistula using argon plasma coagulation (APC), forced mode 40 W ( [Fig. 1a, b](#FI1687-1){ref-type="fig"} ). Subsequently, the PGA sheet (Neoveil; Gunze, Kyoto, Japan) was cut into small pieces, and these were used to fill the fistula using biopsy forceps through the scope channel or over the scope ( [Fig. 1c](#FI1687-1){ref-type="fig"} ). Finally, fibrinogen and thrombin solutions of fibrin glue (Beriplast P Combi-Set; CSL Behring Pharma, Tokyo, Japan) were applied to the PGA sheets ( [Fig. 1d](#FI1687-1){ref-type="fig"} ). Endoclips were occasionally used to secure the mucosa around the fistula, as required.

![Polyglycolic acid (PGA) sheets with fibrin glue application. **a, b** Ablation of the mucosa around the fistula using argon plasma coagulation (APC). **c** PGA sheets (yellow arrow) used to fill the fistula using biopsy forceps through the scope channel or over the scope. **d** Application of fibrinogen and thrombin solutions of fibrin glue to the PGA sheets.](10-1055-a-1119-6352-i1687ei1){#FI1687-1}

Follow-up
---------

Endoscopic evaluation was performed every week after the procedure. Closure of a fistula was defined when a fistula covered by epithelium was confirmed endoscopically or leakage to a fistula was denied with contrast agent. When PGA sheets persisted, endoscopic evaluation was performed 1 week later. We repeated the above procedure for a maximum of four times when the fistula persisted without PGA sheets.

Results
=======

Clinical characteristics
------------------------

Between October 2016 and September 2017, five patients with esophageal fistulas after esophagectomy were enrolled and treated with PGA sheets and fibrin glue. Clinical characteristics of the patients (5 men; median age 71.4 years) are shown in [Table 1](#TB1687-1){ref-type="table"} . All patients were treated with esophagectomy for esophageal cancer (Stage I-III) including two cases treated with video-assisted thoracoscopic esophagectomy. All patients underwent reconstruction via the posterior mediastinal route; in four cases, reconstruction was performed via the gastric tube and in one case, via the jejunum. In two cases, salvage esophagectomy for residual or recurrent esophageal cancer after chemoradiotherapy (CRT) was performed. For Case 4, CRT was performed for lymph node metastasis after esophagectomy. In four cases, esophago-bronchial fistulas were noted and in the remaining cases, esophago-mediastinal fistulas were noted. Small-sized fistulas (2--3 mm) were noted in most cases, except for Case 1 with a 12-mm fistula. The interval from esophagectomy was \> 3 months (median 696, 122--1634 days). Cases 1 and 2 were treated with percutaneous catheter-based drainage. All cases underwent APC before PGA application, and Cases 1, 2, and 5 were treated using endoclips.

###### Patient characteristics.

  Case number   Age, years; sex   Stage of esophageal cancer   Surgery   Reconstruction   Rout                    Chemoradiotherapy   Days since surgery   Location    Size of fistula (mm)   Type of fistula       Outcome   Time to closure (days)
  ------------- ----------------- ---------------------------- --------- ---------------- ----------------------- ------------------- -------------------- ----------- ---------------------- --------------------- --------- ------------------------
  1             71; male          II                           VATS      Gastric tube     Posterior mediastinal   No                  1634                 Right       12                     Esophagobronchial     Failure   --
  2             74; male          III                          Open      Gastric tube     Posterior mediastinal   No                   148                 Posterior    2                     Esophagomediastinal   Success   57
  3             70; male          III                          Open      Jejunum          Posterior mediastinal   Previous             122                 Left         3                     Esophagobronchial     Failure   --
  4             73; male          I                            VATS      Gastric tube     Posterior mediastinal   Additional          1259                 Right        2                     Esophagobronchial     Success   71
  5             69; male          II                           Open      Gastric tube     Posterior mediastinal   Previous             696                 Right        2                     Esophagobronchial     Failure   --

VATS, video-assisted thoracoscopic esophagectomy

Primary and secondary endpoints
-------------------------------

Fistulas were successfully filled with PGA sheets in all cases on the day of the procedure. No adverse events occurred during the endoscopic procedure and post-endoscopic therapy. However, in Cases 3 and 5, fistulas were enlarged after the treatment.

All cases were treated four times with PGA sheets. The closure of fistulas was confirmed in Cases 2 and 4 (40 %, 2/5) endoscopically ( [Fig. 2](#FI1687-2){ref-type="fig"} ). The duration of treatment with PGA sheets required to close the esophageal fistula was 57 days in Case 2 and 71 days in Case 4. Case 1 underwent surgical closure. In Case 3, the fistula was not closed with PGA therapy, but the fistula to the bronchi was closed and the diet meal was started because he needed additional chemotherapy for lymph node metastasis. Case 5 was treated with n-butyl cyanoacrylate after the PGA therapy and the fistula was closed.

![Successful case of closure of esophageal fistula. **a** Endoscopic view showing the esophageal fistula located anastomosis after esophagectomy). **b** Application of polyglycolic acid (PGA) sheets with fibrin glue along with endoclips. **c** Esophageal fistula was observed 1 week later. **d** The same procedure was repeated four times. **e** Fistula covered with granulation tissue. **f** Endoscopic view showing complete closure of the esophageal fistula.](10-1055-a-1119-6352-i1687ei2){#FI1687-2}

Discussion
==========

PGA sheets with fibrin glue for esophageal fistula after esophagectomy was safe without AEs and closed 40 % of esophageal fistulas in the current prospective pilot study. To the best of our knowledge, it is the first prospective study that reports the safety and efficacy of the use of PGA sheets with fibrin glue for esophageal fistulas after esophagectomy.

PGA sheets degrade in the human body within 4--8 weeks [@JR1687-11] . They may help the healing process as scaffolds for tissue regeneration as granulation tissue fills and covers the fistula or perforation site [@JR1687-12] . Inflammation may contribute to promote granulation tissue. PGA sheets and fibrin glue are safe and have been used generally in surgery for the lung, pancreas, and glossa. Recently, their use in endoscopic closure of fistulas or perforation has increased [@JR1687-6] [@JR1687-9] [@JR1687-10] [@JR1687-11] [@JR1687-13] [@JR1687-14] [@JR1687-15] .

No AEs were reported regarding endoscopic closure of fistulas or perforation using PGA sheets and fibrin glue. A retrospective case series also reported no AEs in 10 cases [@JR1687-6] . In our study, fistulas in two cases were enlarged after the treatment. It might depend on using APC coagulation on the thin wall around the fistula. The indication and method of using APC or other coagulation devices will hopefully be elucidated in the future. Nakano reported 70 % (7/10) successful gastrointestinal fistula closure using the PGA sheets and fibrin glue [@JR1687-6] . Limited to esophageal fistula, the success rate of esophageal fistula closure was 57.1 % (4/7). The low success rate in our study may be attributable to the long interval after esophagectomy because the aforementioned report indicated 36 (7--127) days from hole detection to the procedure [@JR1687-6] . Esophageal fistulas caused due to failure of the suture of esophagectomy were treated conservatively by drainage and antibiotics [@JR1687-2] . In addition, they received additional therapy like CRT for residual or metastatic cancer. Therefore, epithelization of the surface of fistula may make difficult for PGA sheets attachment and tissue regeneration. The previous report also showed that fistula closure was not achieved with PGA sheets in both cases with CRT [@JR1687-6] . Furthermore, most of our cases had esophago-bronchial fistulas, which may be difficult to close using the PGA sheets because the breath from bronchi might sometimes blow away the PGA sheets [@JR1687-6] . All esophago-bronchial fistulas failed to close in the above case series [@JR1687-6] . Small-sized fistulas without a bronchial route may be good indicators for this therapy.

Although an approximately 50 % success rate was reported for endoscopic stenting, frequent AEs can occur, such as migration, bleeding, severe pain, stricture, and iatrogenic fistula [@JR1687-1] [@JR1687-2] [@JR1687-3] [@JR1687-4] [@JR1687-16] [@JR1687-17] . OTSC also showed an approximate 50 % success rate; however, it required more working space than use of PGA sheets; sometimes failure and recurrence were also noted for OTSC due to severe fibrosis or poor integrity of the tissue surrounding the fistula [@JR1687-3] [@JR1687-4] [@JR1687-5] [@JR1687-8] [@JR1687-16] [@JR1687-17] . A study performed on a European cohort reported that endoscopic vacuum therapy (EVT) is reportedly better than stenting for successful closure in case of esophageal leakage [@JR1687-16] [@JR1687-17] [@JR1687-18] . However, such open-pore drainage devices are not available in Japan, and EVT requires repeated endoscopic procedures under anesthesia. In addition, most reports on EVT showed to use in an earlier phase after surgery [@JR1687-16] [@JR1687-17] [@JR1687-18] . Therefore, PGA sheets with fibrin glue may be the first treatment for esophageal fistulas after esophagectomy without adverse events. Recently, injection of an alpha-cyanoacrylate monomer successfully closed esophageal fistulas in 88 % of cases without AEs [@JR1687-7] . However, they attempted this therapy in the earlier phase, 1 to 8 days after diagnosing the fistula, which may have affected the results because most fistulas would close just by conservative treatment.

Our study had several limitations. First, this was a small-sample-size single-center study. Large, prospective, randomized studies are needed to evaluate the efficacy of PGA sheets. Second, most patients in the present study were treated with PGA sheets with fibrin glue in the late period since esophagectomy. This may influence the closure of fistulas because epithelization may already be complete, which makes it difficult to attach PGA sheets to tissue and to activate inflammation and granulation.

Conclusion
==========

This study suggests that PGA sheets with fibrin glue were safely used for esophageal fistulas after esophagectomy without AEs and may have the potential to close esophageal fistulas.
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